Results 241 to 250 of about 289,900 (263)
Some of the next articles are maybe not open access.
Poly(ADP-Ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal strategy in the clinic
Ca-A Cancer Journal for Clinicians, 2011Timothy A Yap, Johann Sebastian de Bono
exaly
Therapeutic strategies to target RAS-mutant cancers
Nature Reviews Clinical Oncology, 2018Ryan B Corcoran
exaly
The drug–target residence time model: a 10-year retrospective
Nature Reviews Drug Discovery, 2015Robert A Copeland
exaly
Protein kinase C, an elusive therapeutic target?
Nature Reviews Drug Discovery, 2012Daria Mochly-Rosen
exaly

